Unlock your academic potential and expand your network by joining us!

Dr. Mohammad H. Semreen

Share Link

Share

Information

Mohammad H. Semreen is an Associate Professor of Pharmaceutical Chemistry at the University of Sharjah, United Arab Emirates. He is the chair of the Medicinal Chemistry Department at the College of Pharmacy. He received his Ph.D. from the University of Messina, Italy, in Pharmaceutical Chemistry in 2001. He has been working in the field of drug development and discovery for several years. He has a list of publications in the field of separation sciences with respect to pharmaceuticals and biopharmaceuticals, as well as in the drug discovery arena. In addition to research, he also provides consultation to pharmaceutical industries as well as to regulatory affairs in the technical evaluation of drug registrations. His research interests include the development and validation of advanced analytical techniques such as HPLC, GC, and LC-MS/MS; enantioselective separation; drug stability studies; pharmaceuticals and biopharmaceutical analyses; and the design and synthesis of novel anti-cancer drug leads.

Research Keywords & Expertise

Antibacterial
Pharmaceuticals
compounds
anticancer
resistant

Fingerprints

27%
compounds
22%
resistant
18%
anticancer
13%
Pharmaceuticals
13%
pharmaceutical
5%
Antibacterial

Short Biography

Mohammad H. Semreen is an Associate Professor of Pharmaceutical Chemistry at the University of Sharjah, United Arab Emirates. He is the chair of the Medicinal Chemistry Department at the College of Pharmacy. He received his Ph.D. from the University of Messina, Italy, in Pharmaceutical Chemistry in 2001. He has been working in the field of drug development and discovery for several years. He has a list of publications in the field of separation sciences with respect to pharmaceuticals and biopharmaceuticals, as well as in the drug discovery arena. In addition to research, he also provides consultation to pharmaceutical industries as well as to regulatory affairs in the technical evaluation of drug registrations. His research interests include the development and validation of advanced analytical techniques such as HPLC, GC, and LC-MS/MS; enantioselective separation; drug stability studies; pharmaceuticals and biopharmaceutical analyses; and the design and synthesis of novel anti-cancer drug leads.